| 000 | 01429 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512012829.0 | ||
| 264 | 0 | _c19890921 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00253236 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOtten, J | |
| 245 | 0 | 0 |
_aTreatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study). _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1989 |
||
| 300 |
_aS30 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDactinomycin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
| 650 | 0 | 4 |
_aMesenchymoma _xdrug therapy |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aFlamant, F | |
| 700 | 1 | _aRodary, C | |
| 700 | 1 | _aBrunat-Mentigny, M | |
| 700 | 1 | _aDutou, L | |
| 700 | 1 | _aOlive, D | |
| 700 | 1 | _aQuintana, E | |
| 700 | 1 | _aVoûte, P A | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 24 Suppl 1 _gp. S30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00253236 _zAvailable from publisher's website |
| 999 |
_c2673668 _d2673668 |
||